Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Van Calsteren

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|June 23, 2009
Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancyG G Donders, K Van Calsteren, G Bellen, et al.
Gynecologic and Obstetric Investigation|April 2, 2014
Estradiol and weight are covariates of paracetamol clearance in young womenB Beleyn, S Vermeersch, A Kulo, et al.
International Journal of Obstetric Anesthesia|August 21, 2012
Pharmacokinetics of intravenous ketorolac following caesarean deliveryA Kulo, M van de Velde, K van Calsteren, et al.
European Review for Medical and Pharmacological Sciences|March 27, 2014
Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young womenA Kulo, K Van Calsteren, M van de Velde, et al.
Gynecologic Oncology|September 18, 2010
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon modelK Van Calsteren, R Verbesselt, J Beijnen, et al.
Prenatal Diagnosis|March 21, 2025
Persistent Uninterpretable or Failed Prenatal Cell-Free DNA Screening Indicates a High-Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA-Analysis: A Prospective Cohort StudyL Lannoo, K Van Den Bogaert, A Belmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2014
Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxelJ G C van Hasselt, K van Calsteren, L Heyns, et al.
Eclinicalmedicine|December 9, 2020
The impact of cancer and chemotherapy during pregnancy on child neurodevelopment: A multimodal neuroimaging analysisJ Blommaert, A Radwan, C Sleurs, et al.
Clinical Pharmacokinetics|June 23, 2023
Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic DrugsJ M Janssen, D Damoiseaux, J G C van Hasselt, et al.
Placenta|April 9, 2018
Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restrictionM Verheecke, A Cortès Calabuig, J Finalet Ferreiro, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BJOG : an International Journal of Obstetrics and Gynaecology|June 23, 2009
Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancyG G Donders, K Van Calsteren, G Bellen, et al.
Gynecologic and Obstetric Investigation|April 2, 2014
Estradiol and weight are covariates of paracetamol clearance in young womenB Beleyn, S Vermeersch, A Kulo, et al.
International Journal of Obstetric Anesthesia|August 21, 2012
Pharmacokinetics of intravenous ketorolac following caesarean deliveryA Kulo, M van de Velde, K van Calsteren, et al.
European Review for Medical and Pharmacological Sciences|March 27, 2014
Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young womenA Kulo, K Van Calsteren, M van de Velde, et al.
Gynecologic Oncology|September 18, 2010
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon modelK Van Calsteren, R Verbesselt, J Beijnen, et al.
Prenatal Diagnosis|March 21, 2025
Persistent Uninterpretable or Failed Prenatal Cell-Free DNA Screening Indicates a High-Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA-Analysis: A Prospective Cohort StudyL Lannoo, K Van Den Bogaert, A Belmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2014
Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxelJ G C van Hasselt, K van Calsteren, L Heyns, et al.
Eclinicalmedicine|December 9, 2020
The impact of cancer and chemotherapy during pregnancy on child neurodevelopment: A multimodal neuroimaging analysisJ Blommaert, A Radwan, C Sleurs, et al.
Clinical Pharmacokinetics|June 23, 2023
Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic DrugsJ M Janssen, D Damoiseaux, J G C van Hasselt, et al.
Placenta|April 9, 2018
Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restrictionM Verheecke, A Cortès Calabuig, J Finalet Ferreiro, et al.
Pageof 3